These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2848505)

  • 1. Conversion of biosynthetic human proinsulin to partially cleaved intermediates by collagenase proteinases adsorbed to isolated rat adipocytes.
    Duckworth WC; Peavy DE; Hamel FG; Liepnieks J; Brunner MR; Heiney RE; Frank BH
    Biochem J; 1988 Oct; 255(1):277-84. PubMed ID: 2848505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP; Peavy DE; Frank BH; Duckworth WC
    Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor binding and biological potency of several split forms (conversion intermediates) of human proinsulin. Studies in cultured IM-9 lymphocytes and in vivo and in vitro in rats.
    Peavy DE; Brunner MR; Duckworth WC; Hooker CS; Frank BH
    J Biol Chem; 1985 Nov; 260(26):13989-94. PubMed ID: 4055768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II.
    Sizonenko SV; Halban PA
    Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):621-5. PubMed ID: 1898351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of biosynthetic human proinsulin. Receptor binding and biologic potency of proinsulin and insulin in isolated rat adipocytes.
    Peavy DE; Abram JD; Frank BH; Duckworth WC
    Diabetes; 1984 Nov; 33(11):1062-7. PubMed ID: 6389225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characterization of endosomal insulin degradation intermediates and their sequence of production.
    Seabright PJ; Smith GD
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):947-56. PubMed ID: 9003385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
    Linde S; Sonne O; Hansen B; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintigraphic distribution of 123 I labelled proinsulin, split conversion intermediates and insulin in rats.
    Sodoyez-Goffaux F; Sodoyez JC; Koch M; De Vos CJ; Frank BH
    Diabetologia; 1988 Nov; 31(11):848-54. PubMed ID: 3234639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroendocytosis of insulin in rat adipocytes.
    Levy JR; Olefsky JM
    Endocrinology; 1986 Aug; 119(2):572-9. PubMed ID: 3525121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides.
    Kitabchi AE
    J Clin Invest; 1970 May; 49(5):979-87. PubMed ID: 5309725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-mediated degradation by rat adipocytes: comparison of A-14 with A-19 125I-labelled insulin.
    Watanabe N; Kobayashi M; Ohgaku S; Iwasaki M; Maegawa H; Shigeta Y
    Endocrinol Jpn; 1984 Jun; 31(3):321-6. PubMed ID: 6389102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytotic uptake, processing, and retroendocytosis of human biosynthetic proinsulin by rat fibroblasts transfected with the human insulin receptor gene.
    Levy JR; Ullrich A; Olefsky JM
    J Clin Invest; 1988 May; 81(5):1370-7. PubMed ID: 3284910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology.
    Kobayashi M; Sasaoka T; Sugibayashi M; Iwanishi M; Shigeta Y
    Diabetes Res Clin Pract; 1989 Jun; 7(1):25-8. PubMed ID: 2666066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interactions of proinsulin with insulin receptors on the plasma membrane of the liver.
    Freychet P
    J Clin Invest; 1974 Nov; 54(5):1020-31. PubMed ID: 4421396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin degradation products from perfused rat kidney.
    Duckworth WC; Hamel FG; Liepnieks J; Peavy D; Frank B; Rabkin R
    Am J Physiol; 1989 Feb; 256(2 Pt 1):E208-14. PubMed ID: 2645781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and degradation of 125I-labelled insulin by isolated rat fat cells.
    Gammeltoft S; Gliemann J
    Biochim Biophys Acta; 1973 Aug; 320(1):16-32. PubMed ID: 4748361
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro characterization of biosynthetic human proinsulin.
    Podlecki DA; Frank BH; Olefsky JM
    Diabetes; 1984 Feb; 33(2):111-8. PubMed ID: 6363165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and clinical implications of proinsulin conversion intermediates.
    Given BD; Cohen RM; Shoelson SE; Frank BH; Rubenstein AH; Tager HS
    J Clin Invest; 1985 Oct; 76(4):1398-405. PubMed ID: 3902891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.